News

People with progressive familial intrahepatic cholestasis (PFIC), along with their families and clinicians, collaborated on a two-year project to develop a knowledge base for…

Children and young adults with biliary atresia or Alagille syndrome more frequently experience oral problems and poor oral hygiene than their healthy peers,…

A large clinical trial evaluating Atea Pharmaceuticals’ fixed-dose oral combination of bemnifosbuvir and ruzasvir in adults with chronic hepatitis C remains on track,…

People with primary biliary cholangitis (PBC) who experience itching (pruritus) use more healthcare resources and have significantly higher medical costs than those without this…

A new prediction tool may help assess the risk of preterm birth (before 37 weeks of gestation) in women affected by intrahepatic cholestasis of…

Belapectin, Galectin Therapeutics’ investigational therapy, significantly reduced the development of new enlarged blood vessels in the esophagus among people with metabolic dysfunction-associated steatohepatitis (MASH),…

Due to itching at nighttime, children with Alagille syndrome often experience substantial problems getting a good night’s sleep, leading to poor rest not only…

GlaxoSmithKline (GSK) has submitted an application to Health Canada seeking approval of its chronic hepatitis B therapy bepirovirsen for treating adults with the…

Low blood levels of vitamin B6 — found in certain foods and essential for metabolism and immune function in the body — can increase the…

Rare genetic liver conditions like progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome pose a substantial financial and quality-of-life burden on families, a study…